| 2023-03-10 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 1,054 | $289.16 | $304,779.29 | -0.5% | → |
| 2023-02-27 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 354 | $287.48 | $101,768.23 | -0.2% | → |
| 2023-02-27 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 4,238 | $287.51 | $1,218,449.48 | -4.2% | → |
| 2023-02-27 | Arbuckle Stuart A | EVP, COO | Sell | 5,034 | $287.47 | $1,447,143.44 | -2.8% | → |
| 2023-02-27 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 1,207 | $287.55 | $347,072.40 | -5.2% | → |
| 2023-02-22 | Arbuckle Stuart A | EVP, COO | Sell | 2,401 | $294.33 | $706,678.70 | -0.7% | → |
| 2023-02-21 | Arbuckle Stuart A | EVP, COO | Sell | 2,402 | $293.75 | $705,595.74 | -0.9% | → |
| 2023-02-21 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 480 | $293.75 | $141,001.58 | -0.2% | → |
| 2023-02-21 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 4,002 | $293.77 | $1,175,676.13 | -2.3% | → |
| 2023-02-14 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 4,510 | $298.12 | $1,344,500.21 | -1.7% | → |
| 2023-02-14 | Arbuckle Stuart A | EVP, COO | Sell | 6,398 | $298.68 | $1,910,961.70 | -1.3% | → |
| 2023-02-14 | Sanna Bastiano | EVP, Cell & Genetic Therapies | Sell | 2,181 | $300.39 | $655,161.27 | -1.8% | → |
| 2023-02-14 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 269 | $298.13 | $80,196.93 | -0.1% | → |